Infection Control Market is estimated to increase at a Compounded Annual Growth Rate of 5.9% CAGR over the forecast period from 2024 to 2030
The Infection Control Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Equipment, Services, Consumables), By End-User (Hospitals, Medical Device Companies, Clinical Laboratories, Pharmaceutical Laboratories, Others).
An Introduction to Infection Control Market in 2024
Infection control measures are paramount in healthcare settings to prevent the transmission of pathogens and minimize the risk of healthcare-associated infections (HAIs). In 2024, infection control strategies continue to evolve in response to emerging infectious threats, antimicrobial resistance, and advancements in healthcare technologies. Comprehensive infection prevention programs encompass a range of interventions, including hand hygiene protocols, environmental cleaning and disinfection, antimicrobial stewardship, and surveillance of HAIs. Additionally, the integration of innovative technologies such as ultraviolet (UV) disinfection systems, antimicrobial surfaces, and automated surveillance algorithms enhances the effectiveness and efficiency of infection control efforts. Furthermore, the adoption of multidisciplinary approaches and evidence-based practices fosters a culture of safety and continuous improvement within healthcare organizations. As the global healthcare landscape evolves, the importance of infection control in safeguarding patient safety, preserving antimicrobial efficacy, and mitigating healthcare-associated risks remains paramount, driving ongoing innovation and collaboration in infection prevention and control.
Market Trend: Increasing Emphasis on Healthcare-Associated Infection (HAI) Prevention
A prominent trend in the infection control market is the escalating emphasis on preventing healthcare-associated infections (HAIs). With rising awareness about the economic and public health burden of HAIs, healthcare facilities worldwide are prioritizing infection control measures to reduce transmission rates and improve patient outcomes. This trend is driving the adoption of advanced disinfection technologies, stringent hygiene protocols, and innovative infection control products across hospitals, clinics, long-term care facilities, and other healthcare settings. Additionally, regulatory initiatives and accreditation standards further reinforce the importance of infection prevention practices, shaping the market towards comprehensive solutions that address a wide range of pathogens and transmission routes.
Market Driver: Global Pandemics and Infectious Disease Outbreaks
A key driver propelling the infection control market is the occurrence of global pandemics and infectious disease outbreaks. Events such as the COVID-19 pandemic underscore the critical need for effective infection control strategies to contain the spread of contagious pathogens and safeguard public health. These outbreaks not only heighten awareness about the importance of infection prevention but also stimulate investments in healthcare infrastructure, surveillance systems, and pandemic preparedness measures. The urgency to mitigate the impact of pandemics drives demand for infection control products and services, including personal protective equipment (PPE), disinfectants, air purification systems, and infection surveillance technologies, fueling growth opportunities for industry stakeholders.
Market Opportunity: Integration of Advanced Technologies for Infection Control
An opportunity for innovation and growth in the infection control market lies in the integration of advanced technologies to enhance infection prevention practices. Technologies such as UV-C disinfection, ionization systems, antimicrobial surfaces, and artificial intelligence (AI)-powered monitoring solutions offer promising avenues for mitigating infection risks and improving hygiene standards across diverse settings. Integrating these technologies into existing infection control protocols enables healthcare facilities to achieve greater efficacy, efficiency, and sustainability in combating infectious diseases. Furthermore, the expansion of telemedicine and remote monitoring capabilities presents opportunities to develop and deploy digital health solutions that facilitate infection surveillance, patient education, and remote consultations, thus addressing evolving healthcare needs and strengthening resilience against future outbreaks. By embracing technological innovation, industry players can position themselves at the forefront of infection control advancements and capitalize on the growing demand for comprehensive infection prevention solutions.
Infection Control Market Share Analysis: Disinfectants in the Hospitals Sector is the fastest growing segment over the forecast period to 2030
The Disinfectants segment within the Infection Control Market is experiencing the most rapid growth, particularly in the Hospitals sector, and several factors contribute to this trend. Firstly, hospitals are key settings for preventing and controlling infections due to the high volume of patients, invasive procedures, and presence of pathogens in healthcare environments. Disinfectants play a critical role in infection control by eliminating or reducing microbial contamination on surfaces, medical equipment, and other healthcare facilities. Additionally, the emergence of antibiotic-resistant bacteria and healthcare-associated infections (HAIs) has heightened the importance of effective disinfection practices in hospitals to prevent transmission and outbreaks. Moreover, the ongoing COVID-19 pandemic has further emphasized the need for rigorous disinfection protocols to mitigate the spread of the virus in healthcare settings. This has led to increased demand for disinfectants with proven efficacy against SARS-CoV-2 and other pathogens. Furthermore, advancements in disinfectant formulations, including the development of environmentally friendly and non-toxic disinfectants, have expanded their applications and enhanced their safety profile for use in healthcare facilities. Additionally, regulatory agencies and accreditation bodies impose strict standards and guidelines for infection control in hospitals, driving the adoption of high-quality disinfectants that meet regulatory requirements. Overall, the Disinfectants segment, particularly in the Hospitals sector, is experiencing rapid growth due to the increasing emphasis on infection prevention and control, driven by healthcare-associated infections, antibiotic resistance, and the COVID-19 pandemic.
Infection Control Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across3M Company, Belimed AG, C.R.M. S.R.L. Medical Equipment, Contec Inc, Continental Equipment Company, Ecolab Inc, Fortive Corp, Getinge AB, Matachana Group, Medalkan EE, MELAG Medizintechnik GmbH & Co. KG, Metrex Research LLC, Miele Group (Miele & Cie. KG), MMM Group, Olympus Corp, Pal International Ltd, Reckitt Benckiser Group plc, Sotera Health LLC, Spire Integrated Solutions Inc, STERIS plc, Systec GmbH & Co. KG
Infection Control Market Segmentation
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Infection Control Market Companies
3M Company
Belimed AG
C.R.M. S.R.L. Medical Equipment
Contec Inc
Continental Equipment Company
Ecolab Inc
Fortive Corp
Getinge AB
Matachana Group
Medalkan EE
MELAG Medizintechnik GmbH & Co. KG
Metrex Research LLC
Miele Group (Miele & Cie. KG)
MMM Group
Olympus Corp
Pal International Ltd
Reckitt Benckiser Group plc
Sotera Health LLC
Spire Integrated Solutions Inc
STERIS plc
Systec GmbH & Co. KG
Reasons to Buy the Infection Control Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Infection Control Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Infection Control Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Infection Control Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Infection Control Market Size Outlook, $ Million, 2021 to 2030
3.2 Infection Control Market Outlook by Type, $ Million, 2021 to 2030
3.3 Infection Control Market Outlook by Product, $ Million, 2021 to 2030
3.4 Infection Control Market Outlook by Application, $ Million, 2021 to 2030
3.5 Infection Control Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Infection Control Industry
4.2 Key Market Trends in Infection Control Industry
4.3 Potential Opportunities in Infection Control Industry
4.4 Key Challenges in Infection Control Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Infection Control Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Infection Control Market Outlook by Segments
7.1 Infection Control Market Outlook by Segments, $ Million, 2021- 2030
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
8 North America Infection Control Market Analysis and Outlook To 2030
8.1 Introduction to North America Infection Control Markets in 2024
8.2 North America Infection Control Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Infection Control Market size Outlook by Segments, 2021-2030
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
9 Europe Infection Control Market Analysis and Outlook To 2030
9.1 Introduction to Europe Infection Control Markets in 2024
9.2 Europe Infection Control Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Infection Control Market Size Outlook by Segments, 2021-2030
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
10 Asia Pacific Infection Control Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Infection Control Markets in 2024
10.2 Asia Pacific Infection Control Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Infection Control Market size Outlook by Segments, 2021-2030
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
11 South America Infection Control Market Analysis and Outlook To 2030
11.1 Introduction to South America Infection Control Markets in 2024
11.2 South America Infection Control Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Infection Control Market size Outlook by Segments, 2021-2030
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
12 Middle East and Africa Infection Control Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Infection Control Markets in 2024
12.2 Middle East and Africa Infection Control Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Infection Control Market size Outlook by Segments, 2021-2030
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
3M Company
Belimed AG
C.R.M. S.R.L. Medical Equipment
Contec Inc
Continental Equipment Company
Ecolab Inc
Fortive Corp
Getinge AB
Matachana Group
Medalkan EE
MELAG Medizintechnik GmbH & Co. KG
Metrex Research LLC
Miele Group (Miele & Cie. KG)
MMM Group
Olympus Corp
Pal International Ltd
Reckitt Benckiser Group plc
Sotera Health LLC
Spire Integrated Solutions Inc
STERIS plc
Systec GmbH & Co. KG
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Equipment
-Disinfectors
-Sterilization Equipment
Services
-Contract Sterilization
-Infectious Waste Disposal
Consumables
-Infectious Waste Disposal
-Disinfectants
-Sterilization Consumables
-Personal Protective Equipment
-Others
By End-User
Hospitals
Medical Device Companies
Clinical Laboratories
Pharmaceutical Laboratories
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
